Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized controlled trial of Osigraft (eptotermin alfa) in displaced femoral neck fractures
2005-004149-33Phase 2Terminated
- Sponsor
- Stryker
- Start
- Nov 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of bone morphogenetic protein 7 in Neck Of Femur Fracture (2 arms), sponsored by Stryker. Primary endpoint: Pilot feasibility and planning endpoints for pivotal trial. Started Nov 2005; status: terminated.
02
Drugs
bone morphogenetic protein 7
03
Conditions
Neck Of Femur Fracture
Beyond the preview
Go deeper on 2005-004149-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004149-33.